New research projects at the Kuhn-Hicks laboratory aim to develop computational technologies to map cancer evolution and predict treatment response. Through collaboration with the FDA on breast cancer) and funding by the Adelson Medical Research Foundation for multiple myeloma, the goal of these projects is to deploy novel machine learning and spatiotemporal models that would assist clinicians in treatment decisions. Our very own Peter Kuhn discusses the continuing quest to advance personalized cancer care through convergent science and multi-institutional collaborations. Read more from USC Dornsife news